Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track CPHI with free AI briefings, catalyst countdowns, and dilution alerts.

CPHI · CHINA PHARMA HOLDINGS, INC.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$304,874 Cash on Hand
20.8mo Cash Runway
Follow CPHI by email Get an email when CPHI reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about CPHI, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

CPHI holds $304,874 in cash and short-term investments (as of Jun 30, 2026) and burns about $44,060/quarter from operations, an estimated runway of 20.8 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 23 · Moderate

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when CPHI files for a raise →

👥 Who Owns CPHI

Insiders 34.9% Institutions (10 holders) 1.2% Public and other holders 63.9%
HolderTypeShares% of sharesAs of
Tao (Chengdu) Liu
10% owner
Insider 15,000,000 34.87% 2023-12-28

Share count 43,022,002 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full CPHI picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for CPHI and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.